Like plz_老虎社区_美港股上老虎

Annie_ann29
2021-12-27

Like plz

S.Korea authorises emergency use of Pfizer's oral coronavirus treatment

SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-1

S.Korea authorises emergency use of Pfizer's oral coronavirus treatment

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":696996491,"tweetId":"696996491","gmtCreate":1640591465134,"gmtModify":1640591465619,"author":{"id":4088678216292640,"authorId":4088678216292640,"authorIdStr":"4088678216292640","name":"Annie_ann29","avatar":"https://static.tigerbbs.com/74b75bf973f051fd1f70b054cc66a45c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":36,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Like plz</p></body></html>","htmlText":"<html><head></head><body><p>Like plz</p></body></html>","text":"Like plz","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/696996491","repostId":2194103594,"repostType":4,"repost":{"id":"2194103594","pubTimestamp":1640589540,"share":"https://www.laohu8.com/m/news/2194103594?lang=&edition=full","pubTime":"2021-12-27 15:19","market":"us","language":"en","title":"S.Korea authorises emergency use of Pfizer's oral coronavirus treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2194103594","media":"StreetInsider","summary":"SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-1","content":"<p>SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety said on Monday.</p>\n<p>South Korea restored tough distancing curbs last week after easing them in November, after a series of record daily new infections and serious cases stretched medical services, despite a vaccination rate of over 92% for those aged 18 or older.</p>\n<p>Pfizer's oral antiviral treatment, called Paxlovid, is \"expected to help prevent serious deterioration of patients admitted to residential treatment centers or being treated at home,\" by diversifying coronavirus treatments beyond injections currently used in the field, drug safety minister Kim Gang-lip told a press briefing.</p>\n<p>The drug will be used for adults or children 12 years or older weighing over 40 kilograms with mild to moderate symptoms with a high risk of developing a severe case of coronavirus due to causes such as underlying diseases.</p>\n<p>Another oral coronavirus treatment called molnupiravir, developed by Merck known as MSD outside of the United States and Canada, applied for emergency use earlier this month, but the ministry is still reviewing as they need additional info on efficacy, Kim said.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S.Korea authorises emergency use of Pfizer's oral coronavirus treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS.Korea authorises emergency use of Pfizer's oral coronavirus treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 15:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19391217><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19391217\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19391217","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194103594","content_text":"SEOUL (Reuters) -South Korea authorised for emergency use Pfizer's antiviral pills targeting COVID-19 as the first of its kind to be introduced in South Korea, the Ministry of Food and Drug Safety said on Monday.\nSouth Korea restored tough distancing curbs last week after easing them in November, after a series of record daily new infections and serious cases stretched medical services, despite a vaccination rate of over 92% for those aged 18 or older.\nPfizer's oral antiviral treatment, called Paxlovid, is \"expected to help prevent serious deterioration of patients admitted to residential treatment centers or being treated at home,\" by diversifying coronavirus treatments beyond injections currently used in the field, drug safety minister Kim Gang-lip told a press briefing.\nThe drug will be used for adults or children 12 years or older weighing over 40 kilograms with mild to moderate symptoms with a high risk of developing a severe case of coronavirus due to causes such as underlying diseases.\nAnother oral coronavirus treatment called molnupiravir, developed by Merck known as MSD outside of the United States and Canada, applied for emergency use earlier this month, but the ministry is still reviewing as they need additional info on efficacy, Kim said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":641,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

S.Korea authorises emergency use of Pfizer's oral coronavirus treatment

评论（1）

热议股票